ATA322783A - Verfahren zur stabilisierung einer festen pharmazeutischen zusammensetzung - Google Patents
Verfahren zur stabilisierung einer festen pharmazeutischen zusammensetzungInfo
- Publication number
- ATA322783A ATA322783A AT0322783A AT322783A ATA322783A AT A322783 A ATA322783 A AT A322783A AT 0322783 A AT0322783 A AT 0322783A AT 322783 A AT322783 A AT 322783A AT A322783 A ATA322783 A AT A322783A
- Authority
- AT
- Austria
- Prior art keywords
- stabilizing
- pharmaceutical composition
- solid pharmaceutical
- solid
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8225853 | 1982-09-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA322783A true ATA322783A (de) | 1989-01-15 |
| AT388671B AT388671B (de) | 1989-08-10 |
Family
ID=10532830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0322783A AT388671B (de) | 1982-09-10 | 1983-09-09 | Verfahren zur stabilisierung einer festen pharmazeutischen zusammensetzung |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4582830A (de) |
| JP (1) | JPS5973518A (de) |
| KR (1) | KR880001094B1 (de) |
| AT (1) | AT388671B (de) |
| AU (1) | AU566245B2 (de) |
| BE (1) | BE897721A (de) |
| CA (1) | CA1215647A (de) |
| CH (1) | CH655008A5 (de) |
| DE (1) | DE3332616C2 (de) |
| DK (1) | DK161304C (de) |
| ES (1) | ES525492A0 (de) |
| FR (1) | FR2532849B1 (de) |
| GB (1) | GB2126479B (de) |
| IE (1) | IE55720B1 (de) |
| IT (1) | IT1197708B (de) |
| NL (1) | NL189948C (de) |
| NZ (1) | NZ205539A (de) |
| PT (1) | PT77323B (de) |
| SE (1) | SE464615B (de) |
| ZA (1) | ZA836703B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626534A (en) * | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
| AT393452B (de) * | 1985-08-05 | 1991-10-25 | Bristol Myers Squibb Co | Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung |
| JPH02500591A (ja) * | 1987-05-27 | 1990-03-01 | アクゾ・エヌ・ヴエー | β‐ラクタム抗生物質の乾燥した急速溶解性の組成物 |
| IE61679B1 (en) * | 1987-08-10 | 1994-11-16 | Fujisawa Pharmaceutical Co | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
| WO1996017578A1 (fr) * | 1994-12-08 | 1996-06-13 | Otsuka Pharmaceutical Factory, Inc. | Procede pour supprimer l'adsorption de substances derivees du materiau recipient sur les medicaments et recipient |
| HRP970281B1 (en) * | 1996-05-28 | 2002-04-30 | Merck & Co Inc | Carbapenem antibiotic, composition and method of preparation |
| CA2239331C (en) * | 1998-05-29 | 1999-11-30 | Bernard Charles Sherman | Pharmaceutical tablets comprising cefuroxime axetil |
| JP4700291B2 (ja) * | 2003-04-28 | 2011-06-15 | 武田薬品工業株式会社 | 注射用組成物 |
| EP1618894B1 (de) * | 2003-04-28 | 2018-06-13 | Takeda Pharmaceutical Company Limited | Zusammensetzung zur injektion |
| EP1625859A1 (de) * | 2004-08-13 | 2006-02-15 | Access Group ApS | Verfahren zur Aufbereitung einer Verpackung, welche sterilisierte Stoffe beinhaltet, sowie Verpackung, welche sterilisiertes Penizillin beinhaltet |
| CN102920710B (zh) * | 2012-11-16 | 2014-05-28 | 罗诚 | 一种头孢地嗪化合物的药物组合物 |
| CN103432137B (zh) * | 2013-08-28 | 2015-01-28 | 芦红代 | 头孢西丁的药物组合物 |
| CN113350511B (zh) * | 2021-03-01 | 2024-01-02 | 郎俊娜 | 一种新型注射用无菌粉末灌装混合保护气 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB737242A (en) * | 1952-10-16 | 1955-09-21 | Novo Terapeutisk Labor As | Process of increasing the physical stability of aqueous suspensions of penicillin compounds |
| GB760087A (en) * | 1952-10-16 | 1956-10-31 | Novo Terapeutisk Labor As | Process of increasing the physical stability of aqueous suspensions of penicillin compounds |
| GB1132583A (en) * | 1964-12-16 | 1968-11-06 | Glaxo Lab Ltd | Pharmaceutical compositions containing cephalosporins |
| GB1276839A (en) * | 1968-08-02 | 1972-06-07 | Sandoz Products Ltd | Antibiotic compositions |
| AT307616B (de) * | 1969-05-02 | 1973-05-25 | Biochemie Gmbh | Verfahren zur Herstellung einer Brausezubereitung |
| GB1380741A (en) * | 1971-02-05 | 1975-01-15 | Squibb & Sons Inc | Antibiotic compositions and their preparation |
| US3940483A (en) * | 1971-02-05 | 1976-02-24 | E. R. Squibb & Sons, Inc. | Antibiotic compositions and method |
| LU65921A1 (de) * | 1972-08-18 | 1974-02-21 | ||
| US4160829A (en) * | 1972-12-22 | 1979-07-10 | Gist-Brocades N.V. | Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins |
| US3969524A (en) * | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
| GB1463563A (en) * | 1974-10-10 | 1977-02-02 | Beecham Group Ltd | Pharmaceutical compositions |
| DE2461969A1 (de) * | 1974-12-31 | 1976-07-08 | Behringwerke Ag | Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen |
| CA1051780A (en) * | 1975-04-09 | 1979-04-03 | Bahram Farhadieh | Stable chelocardin composition |
| GB1575905A (en) * | 1976-04-28 | 1980-10-01 | Glaxo Lab Ltd | Salt of cefuroxime |
| GB1504767A (en) * | 1976-08-23 | 1978-03-22 | Beecham Group Ltd | Antibiotic compositions |
| JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
| FR2403078A1 (fr) * | 1977-09-19 | 1979-04-13 | Lafon Labor | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
| GB2006769A (en) * | 1977-10-10 | 1979-05-10 | Glaxo Group Ltd | -lactam compounds processes for their preparation pharmaceutical compositions containing them and intermediates of use in their preparation |
| AR228726A1 (es) * | 1978-05-26 | 1983-04-15 | Glaxo Group Ltd | Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato |
| PT70225A (en) * | 1978-10-03 | 1979-10-01 | Gist Brocades Nv | Process for the preparation of sodium amoxicillin preparations |
| US4235900A (en) * | 1978-11-15 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Cephradine compositions |
| FR2445833A1 (fr) * | 1979-01-04 | 1980-08-01 | Chimie Biolog | Nouveaux sels d'antibiotiques amines a cycle beta lactame |
| US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
-
1983
- 1983-09-08 ES ES525492A patent/ES525492A0/es active Granted
- 1983-09-09 DE DE3332616A patent/DE3332616C2/de not_active Expired - Lifetime
- 1983-09-09 NZ NZ205539A patent/NZ205539A/en unknown
- 1983-09-09 PT PT77323A patent/PT77323B/pt active IP Right Revival
- 1983-09-09 CA CA000436412A patent/CA1215647A/en not_active Expired
- 1983-09-09 US US06/530,655 patent/US4582830A/en not_active Expired - Lifetime
- 1983-09-09 SE SE8304857A patent/SE464615B/sv not_active IP Right Cessation
- 1983-09-09 IT IT48950/83A patent/IT1197708B/it active Protection Beyond IP Right Term
- 1983-09-09 KR KR1019830004246A patent/KR880001094B1/ko not_active IP Right Cessation
- 1983-09-09 IE IE2118/83A patent/IE55720B1/en not_active IP Right Cessation
- 1983-09-09 AT AT0322783A patent/AT388671B/de not_active IP Right Cessation
- 1983-09-09 BE BE0/211503A patent/BE897721A/fr not_active IP Right Cessation
- 1983-09-09 JP JP58165286A patent/JPS5973518A/ja active Granted
- 1983-09-09 NL NLAANVRAGE8303125,A patent/NL189948C/xx not_active IP Right Cessation
- 1983-09-09 CH CH4937/83A patent/CH655008A5/de not_active IP Right Cessation
- 1983-09-09 FR FR8314396A patent/FR2532849B1/fr not_active Expired
- 1983-09-09 AU AU18975/83A patent/AU566245B2/en not_active Expired
- 1983-09-09 ZA ZA836703A patent/ZA836703B/xx unknown
- 1983-09-09 DK DK409183A patent/DK161304C/da not_active IP Right Cessation
- 1983-09-09 GB GB08324133A patent/GB2126479B/en not_active Expired
-
1987
- 1987-06-04 US US07/058,119 patent/US4803196A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT381638B (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation | |
| AT377438B (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung | |
| AT382779B (de) | Verfahren zur herstellung von festen pharmazeutischen dispersionszusammensetzungen mit rascher wirkstofffreisetzung | |
| DE3675707D1 (de) | Verfahren zur bekaempfung von mollusken. | |
| AT388671B (de) | Verfahren zur stabilisierung einer festen pharmazeutischen zusammensetzung | |
| ATA337285A (de) | Verfahren zur herstellung von isosilybinfreiem silibinin | |
| AT371744B (de) | Verfahren zur herstellung von foerderschnecken | |
| ATA221181A (de) | Verfahren zur herstellung von einer pharmazeutischen zusammensetzung | |
| AT389512B (de) | Verfahren zur herstellung von 3-chlormethylchinuclidin | |
| ATA40688A (de) | Verfahren zur hydrophobierung von gipsbauelementen | |
| AT373859B (de) | Verfahren zur gewinnung von zink | |
| AT383272B (de) | Verfahren zur herstellung von pharmazeutischen tabletten | |
| AT380480B (de) | Verfahren zur herstellung von anthracyclinglykosiden | |
| ATA369484A (de) | Verfahren zur emulsionspolymerisation | |
| AT383735B (de) | Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen | |
| ATA462982A (de) | Verfahren zur verhinderung von oberflaechenst | |
| AT379828B (de) | Verfahren zur herstellung von antracyclinen antibiotica | |
| AT388374B (de) | Verfahren zur herstellung von n-sulfonylaryloxybenzamiden | |
| ATA201283A (de) | Verfahren zur herstellung von carboxyalkyldipeptiden | |
| ATA317883A (de) | Verfahren zur gewinnung von reinem hellebrin | |
| ATA206087A (de) | Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung | |
| ATA221080A (de) | Verfahren zur herstellung einer pharmazeutischen zubereitung | |
| AT378189B (de) | Verfahren zur trennung von interphenylen-9-thia-11-oxo-12-azaprostansaeuren | |
| AT383736B (de) | Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen | |
| ATA45285A (de) | Verfahren zur untertitelung von 35mm-filmen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |